Investigating aCute heArt failuRe Decongestion Guided by Lung UltraSonography
Recruiting
N/A
Interventional Study
Acute Heart Failure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 222 (estimated)
- Sponsor
- Antonio Leidi · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to investigate whether a lung ultrasonography (LUS)-guided decongestion strategy in adults hospitalized for acute heart failure (AHF) can improve patient-centered outcomes.
The main questions it aims to answer are:
* Does this strategy shorten the length of stay and reduce early hospital readmissions?
* Does this strategy improve patients' symptoms and quality …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* ≥ 18 years old
* Planned or actual admission to intermediate care units, general internal medical or cardiology wards
* Diagnosis of congestive AHF on admission chart (primary or secondary diagnosis)
* Raised value of N terminal-pro-brain natriuretic peptide (≥1000 ng/l).
Key…
Contacts
No contact information available.